MG
VIR icon

Michael Gelband’s Vir Biotechnology VIR Stock Holding History

Michael Gelband’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-137,059
Closed -$1.23M – 2109
2026
Q1 		$1.23M Sell
137,059
-40,044
-23% -$319K 0.01% 938
2025
Q4 		$1.07M Buy
177,103
+17,236
+11% +$103K 0.01% 975
2025
Q3 		$913K Buy
159,867
+106,874
+202% +$546K 0.01% 997
2025
Q2 		$267K Buy
+52,993
New +$284K ﹤0.01% 1264
2025
Q1 		– Sell
-246,833
Closed -$1.81M – 2036
2024
Q4 		$1.81M Buy
+246,833
New +$1.95M 0.01% 751
2024
Q2 		– Sell
-33,607
Closed -$340K – 2012
2024
Q1 		$340K Sell
33,607
-104,619
-76% -$1.07M ﹤0.01% 1227
2023
Q4 		$1.39M Buy
138,226
+57,132
+70% +$522K 0.01% 689
2023
Q3 		$760K Buy
81,094
+62,720
+341% +$895K 0.01% 1066
2023
Q2 		$451K Sell
18,374
-20,518
-53% -$515K ﹤0.01% 1395
2023
Q1 		$905K Buy
38,892
+14,767
+61% +$378K 0.01% 1173
2022
Q4 		$611K Sell
24,125
-15,243
-39% -$374K 0.01% 1104
2022
Q3 		$759K Sell
39,368
-5,600
-12% -$142K 0.01% 1219
2022
Q2 		$1.15M Sell
44,968
-12,359
-22% -$289K 0.01% 1022
2022
Q1 		$1.47M Buy
+57,327
New +$1.7M 0.02% 930
2021
Q2 		– Sell
-18,790
Closed -$963K – 2840
2021
Q1 		$963K Buy
+18,790
New +$1.01M 0.01% 939

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Michael Gelband's VIR Position: Q2 2026 in Review

Michael Gelband sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 137,059 shares — an estimated $1.23M sold.

Michael Gelband first reported a position in VIR in Q1 2021 and held it in 15 quarters. The position peaked at $1.81M in Q4 2024. 236 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Michael Gelband reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 137,059 Vir Biotechnology shares in Q2 2026, an estimated $1.23M.
  • Michael Gelband first reported a position in Vir Biotechnology in Q1 2021 and held it in 15 quarters.
  • Michael Gelband's Vir Biotechnology position peaked at $1.81M in Q4 2024.
  • 236 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.